- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
CapsoVision, Inc. Common Stock(CV)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CV
11/13/2026: CV (1-star) is a SELL. SELL for 3 days. Simulated Profits (-7.79%). Updated daily EoD!
CapsoVision is a commercial-stage medical technology company specializing in gastrointestinal diagnostic imaging solutions like the CapsoCam Plus capsule endoscope. Its primary business strengths lie in its unique 360-degree panoramic camera design and recent integrations of AI-driven diagnostic highlight features. The main investment story centers on expanding hospital adoption and software utilization in the non-invasive small-bowel screening market. However, the company faces notable execution risks, ongoing net operating losses, and intense competition from dominant industry incumbents like Medtronic. The stock suits growth-oriented investors with a high risk tolerance willing to monitor clinical adoption milestones and cash burn trends.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While operating in an innovative medical device niche with expanding revenues, its small scale introduces higher execution uncertainty. |
| Momentum investor | Strong fit while signal remains positive | Short-term momentum can spike around regulatory approvals and clinical data updates, subject to an active upturn signal. |
| Value investor | Weak fit | The company lacks current profitability and positive earnings, making traditional value metrics unsupportable. |
| Dividend investor | Weak fit | CapsoVision does not pay dividends and retains all capital for business expansion. |
| Low-risk investor | Weak fit | High share price volatility and ongoing net losses create elevated risk exposure for conservative capital. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock experiences significant price swings characteristic of small-cap commercial-stage medical device equities. |
| Valuation risk | Medium / high | Valuation relies heavily on long-term future adoption expectations rather than current earnings power. |
| Competition risk (Medtronic and major medtech) | High | Well-funded competitors possess superior marketing resources and entrenched hospital distribution channels. |
| Business quality | Medium | Proprietary medical technology provides an operational niche, but financial self-sustainability is still under development. |
| Dividend income | Low / none | No cash distributions or dividends are paid to shareholders. |
| Execution risk | High | Commercial success depends heavily on expanding physician adoption and navigating complex medical reimbursement structures. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 323.27M USD | Price to earnings Ratio - | 1Y Target Price 9.5 |
Price to earnings Ratio - | 1Y Target Price 9.5 | ||
Volume (30-day avg) 119.5K shares | Beta - | 52 Weeks Range 4.50 - 15.37 | Updated Date 11/15/2026 |
52 Weeks Range 4.50 - 15.37 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.42 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Medical Devices
- BUY participation
- 62.5%
- Active BUY / eligible
- 5 / 8
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Steady Uptrend
The stock demonstrates consistent and steady upward price momentum.

Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit 46.24% | Avg. Invested days 27 | Today’s Advisory SELL |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Capsule Endoscopy Hardware Sales | Revenues generated from the sale of single-use CapsoCam Plus capsules to clinics, hospitals, and medical distributors. | This is the core physical product engine driving daily device utilization. |
| Software and Ancillary Solutions | Licensing and utilization fees associated with CapsoView and CapsoCloud diagnostic software platforms. | Software offerings provide recurring touchpoints and workflow integration for clinical users. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE - | Enterprise Value 302.29M | Price to Sales(TTM) 23.22 |
Enterprise Value 302.29M | Price to Sales(TTM) 23.22 | ||
Enterprise Value to Revenue 21.71 | Enterprise Value to EBITDA - | Shares Outstanding 53.61M | Shares Floating 29.97M |
Shares Outstanding 53.61M | Shares Floating 29.97M | ||
Percent Insiders 33.72 | Percent Institutions 11.96 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

